Innova Therapeutics
Focus: Innova Therapeutics is a publicly-traded biotech company founded in 2020 specializing in monoclonal antibodies for oncology, headquartered in Mt. Pleasant, South Carolina. The company maintains a portfolio spanning talc-based products, radiopharmaceuticals, and a diverse pipeline of early-stage programs and medical devices.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Innova Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Innova Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Innova Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
21 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Declining
LOE Approaching
NDA-approved talc formulation approaching loss of exclusivity, representing legacy revenue at risk.
Help build intelligence for Innova Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.